Importance of rational pre-clinical development: Gemcitabine comes of age: Cancer Biology & Therapy: Vol 4, No 8

113

Views

CrossRef citations to date

Altmetric

Abstract

Commentary to:

Potentiation of the Antitumoral Activity of Gemcitabine and Paclitaxel in Combination on Human Breast Cancer Cells

Gabriella Zupi, Marco Scarsella, Carmen D’Angelo, Annamaria Biroccio, Giancarlo Paoletti, Massimo Lopez and Carlo Leonetti

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Importance of rational pre-clinical development: Gemcitabine comes of age

Information for

Open access

Opportunities

Help and information

Importance of rational pre-clinical development: Gemcitabine comes of age

Abstract

Reprints and Corporate Permissions

Academic Permissions

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date

Your download is now in progress and you may close this window

Login or register to access this feature